ADRB1 and colorectal carcinoma: Our findings do not confirm that suppression of phasic contractions by (-)-isoprenaline is most sensitive to β1-AR blockers (Gillespie et al., 2015b), because we did not observe any shift in CRC with CGP 20712A.